Heimdall Insights

Global Narcolepsy Drugs Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Narcolepsy Drugs Market was valued at $4.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.5% CAGR, to an estimated market size of $6.0 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global narcolepsy drugs market comprises pharmaceutical treatments and therapeutic agents specifically developed to manage the symptoms of narcolepsy, including excessive daytime sleepiness (EDS), cataplexy, and sleep-wake instability. The scope includes central nervous system (CNS) stimulants, sodium oxybate formulations, and emerging orexin receptor agonists, while excluding non-pharmacological behavioral therapies and general over-the-counter sleep aids.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Narcolepsy Drugs Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Sodium Oxybate
  • CNS Stimulants
  • Other Therapeutics (Pitolisant, Antidepressants)